ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,608, issued on May 19, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Stabilized receptor polypeptides and uses thereof" was invented by Jeonghoon Sun (Poway, Calif.), Lei-Ting Tony Tam (Thousand Oaks, Calif.), Mark Leo Michaels (Encino, Calif.), Thomas Charles Boone (Newbury Park, Calif.), Rohini R. Deshpande (Camarillo, Calif.), Yue-Sheng Li (Cambridge, Mass.) and Huiquan Han (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also ...